This paper documents key features of the Cost/ Benefit Model of Diabetes Prevention and Care, which was developed by the National Centre for Social and Economic Modelling (NATSEM) in collaboration with the Diabetes Centre at the Prince of Wales Hospital in Sydney. The model can simulate both Type 1 and Type 2 diabetes. However, because the Type 1 and Type 2 diabetes submodels have identical structures, and because most people with diabetes have Type 2 diabetes, the data sources described in this paper are for Type 2 only. The model is of the dynamic group type and accounts for the incidence and progression of diabetes complications within the Australian population (as it is projected from 1995 to 2050). The model is designed to assess the cost impacts and health outcomes of a range of interventions in diabetes care and prevention. Its aim is to facilitate the ranking of various proposed, past or ongoing interventions and thus help Australian decision makers to, for example, set priorities and select and evaluate intervention programs. This paper describes the structure of the Cost/Benefit Model of Diabetes Prevention and Care and lists the data sources used and assumptions embedded in the model. The paper validates the model through .checks. of model outputs against data published by other organisations. The paper also discusses the sensitivity of model outputs to changes in certain key assumptions.
|Place of Publication||Australia|
|Number of pages||62|
|Publication status||Published - 2003|